196
Participants
Start Date
November 2, 2009
Primary Completion Date
November 10, 2010
Study Completion Date
November 10, 2010
GSK239512
Histamine H3 Antagonist
Placebo
Placebo to match GSK239512
GSK Investigational Site, Sofia
GSK Investigational Site, Sofia
GSK Investigational Site, Achim
GSK Investigational Site, Hanover
GSK Investigational Site, Bochum
GSK Investigational Site, Hattingen
GSK Investigational Site, Cologne
GSK Investigational Site, Cologne
GSK Investigational Site, Pardubice
GSK Investigational Site, Munich
GSK Investigational Site, Nuremberg
GSK Investigational Site, Moscow
GSK Investigational Site, Moscow
GSK Investigational Site, Yaroslavl
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Rostov-on-Don
GSK Investigational Site, Voronezh
GSK Investigational Site, Saratov
GSK Investigational Site, Yekaterinburg
GSK Investigational Site, Santiago
GSK Investigational Site, Rousse
GSK Investigational Site, Santiago
GSK Investigational Site, Viña del Mar
GSK Investigational Site, Prague
GSK Investigational Site, Prague
GSK Investigational Site, Prague
GSK Investigational Site, Trutnov
GSK Investigational Site, Košice
GSK Investigational Site, Levoča
GSK Investigational Site, Michalovce
GSK Investigational Site, Seongnam-si
GSK Investigational Site, Seoul
GSK Investigational Site, Bradford
GSK Investigational Site, Cambridge
GSK Investigational Site, Glasgow
Lead Sponsor
GlaxoSmithKline
INDUSTRY